Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents

Simple item page
dc.contributor.authorLambert, Stephen B
dc.contributor.authorChuk, Lai-man R.
dc.contributor.authorNissen, Michael D.
dc.contributor.authorNolan, Terry
dc.contributor.authorMcVernon, Jodie
dc.contributor.authorBooy, Robert
dc.contributor.authorHeron, L
dc.contributor.authorRichmond, Peter
dc.contributor.authorWalls, Tony
dc.contributor.authorMarshall, Helen
dc.contributor.authorReynolds, Graham
dc.contributor.authorHartel, Gunter F.
dc.contributor.authorHu, Wilson
dc.contributor.authorLai, Michael
dc.date.accessioned2015-12-13T22:26:59Z
dc.date.issued2013
dc.date.updated2016-02-24T09:17:37Z
dc.description.abstractObjective: To evaluate the safety of CSL's split-virion inactivated trivalent 2009 Southern Hemisphere formulation influenza vaccine (TIV) in children. Methods: We enrolled 1992 healthy children into three groups: Cohorts A, ≥6 months to <3 years; B,
dc.identifier.issn1750-2640
dc.identifier.urihttp://hdl.handle.net/1885/73744
dc.publisherWiley-Blackwell
dc.rightsAuthor/s retain copyrighten_AU
dc.sourceInfluenza and Other Respiratory Viruses
dc.subjectKeywords: antipyretic agent; ibuprofen; influenza vaccine; oral rehydration solution; paracetamol; adolescent; adult; anorexia; article; axilla temperature; child; diarrhea; drug formulation; drug safety; drug tolerability; febrile convulsion; female; fever; flu li Adverse events; Fever; Influenza vaccine; Paediatrics; Safety
dc.titleSafety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents
dc.typeJournal article
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue5
local.bibliographicCitation.lastpage685
local.bibliographicCitation.startpage676
local.contributor.affiliationLambert, Stephen B, Queensland Children's Medical Research Institute
local.contributor.affiliationChuk, Lai-man R., Queensland Children’s Health Services & Clinical Medical Virology Centre
local.contributor.affiliationNissen, Michael D., Queensland Children’s Health Services & Clinical Medical Virology Centre
local.contributor.affiliationNolan, Terry, University of Melbourne
local.contributor.affiliationMcVernon, Jodie, University of Melbourne
local.contributor.affiliationBooy, Robert, Children's Hospital at Westmead
local.contributor.affiliationHeron, L, Children's Hospital at Westmead
local.contributor.affiliationRichmond, Peter, University of Western Australia
local.contributor.affiliationWalls, Tony, Sydney Children’s Hospital
local.contributor.affiliationMarshall, Helen, University of Adelaide
local.contributor.affiliationReynolds, Graham, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationHartel, Gunter F., CSL Limited
local.contributor.affiliationHu, Wilson, CSL Limited
local.contributor.affiliationLai, Michael, CSL Limited
local.contributor.authoruidReynolds, Graham, u4043307
local.description.notesImported from ARIES
local.identifier.absfor110300 - CLINICAL SCIENCES
local.identifier.ariespublicationf5625xPUB3812
local.identifier.citationvolume7
local.identifier.doi10.1111/irv.12107
local.identifier.scopusID2-s2.0-84882717451
local.identifier.thomsonID000328162300013
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Lambert_Safety_and_tolerability_of_a_2013.pdf
Size:
174.66 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS